Sector portfolio · VC firm · United States

Alexandria Real Estate Equities' Biotech portfolio

Alexandria Real Estate Equities has backed 78 Biotech startups in rounds we track, $7.4B between them, shown by the stage each has reached. The best-funded is Moderna.

78startups backed
4stages
$7.4Braised between them
Series Bbiggest stage

Alexandria Real Estate Equities's profile

Series B

27

+3 more

Series A

22

Series C and later

18

Stage not reported

11

Segment by segment

Series B

27 startups · $2.7B raised

  1. Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.United States$335M
  2. Strand TherapeuticsStrand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.United States$267M
  3. Stoke TherapeuticsStoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.United States$255M
  4. CTCapstan TherapeuticsCapstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.United States$175M
  5. Homology MedicinesHomology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.United States$144M
  6. Sidewinder TherapeuticsSidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.United States$137M
  7. Syros PharmaceuticalsSyros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.United States$128M
  8. SonoTheraSonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies.United States$125M

Series A

22 startups · $853M raised

  1. Jasper TherapeuticsJasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.United States$167M
  2. PPrevail-$75M
  3. CelsiusCelsius Network is a decentralized financial services platform founded in 2017, focused on bridging traditional finance and blockcUnited States$65M
  4. XX-VaxUnited States$56M
  5. EExpansionUnited States$55M
  6. Quentis TherapeuticsQuentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.United States$49M
  7. RibometrixRibometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases.United States$45M
  8. VVtesseUnited States$42M

Series C and later

18 startups · $3.3B raised

  1. ModernaLearn how we’re changing the world of medicine.United States$675M
  2. Eikon TherapeuticsEikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.United States$351M
  3. EeGenesisUnited States$329M
  4. LifeMine TherapeuticsLifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.United States$230M
  5. Obsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.United States$210M
  6. Dewpoint TherapeuticsDewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.United States$196M
  7. MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
  8. KSQ TherapeuticsKSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.United States$156M

Stage not reported

11 startups · $549M raised

  1. PPrecisionUnited States$111M
  2. MetabolonMetabolon offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine.United States$86M
  3. Frequency TherapeuticsFrequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.United States$74M
  4. HAYA TherapeuticsHAYA Therapeutics, SA is a precision medicine and biotechnology company focused on developing innovative genomic medicines.Switzerland$67M
  5. CCydanUnited States$60M
  6. GBGreenLigh BiosciencesUnited States$50M
  7. Veralox TherapeuticsVERALOX Therapeutics is a clinical-stage biotechnology company based in Frederick, Maryland.United States$41M
  8. KytopenKytopen is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 as an MIT spin-out.United States$35M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Alexandria Real Estate Equities as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Alexandria Real Estate Equities105 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179BSector portfolioSequoia Capital's AI portfolio209 startups · $543B

Raising from investors like Alexandria Real Estate Equities?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps